Related Experiment Video
Updated: Aug 5, 2026

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice
Published on: February 22, 2019
Enteric vaccines for pediatric use. Workshop summary
Richard I Walker1, Lillian L Van De Verg, Robert H Hall
1Division of Bacterial, Parasitic and Allergenic Products, Center for Biologics Evaluation and Research, Food and Drug Administration, 1401 Rockville Pike (HFM-425), Rockville, MD 20851-1448, USA. walkerri@cber.fda.gov
Insights
Developing enteric vaccines is crucial for reducing child mortality from diarrheal diseases in less developed countries (LDCs). A workshop confirmed no major roadblocks exist for creating these vital pediatric vaccines.
Area of Science:
- Global Health
- Vaccinology
- Pediatric Infectious Diseases
Background:
- Diarrheal diseases are a leading cause of mortality in children under five in less developed countries (LDCs).
- Vaccine development presents a critical near-term strategy to address this global health challenge.
Framework:
- The workshop focused on critical aspects of enteric vaccine advancement.
- Key areas included research and development needs, regulatory pathways, and business considerations.
- Past experiences with enteric vaccine development and implementation were also reviewed.
Implementation:
- Discussants identified no insurmountable obstacles to progressing enteric vaccine initiatives.
- The potential exists for successful development and deployment of these vaccines.
- Adequate support is crucial for realizing the availability of enteric vaccines for children.
Implications:
- Successful implementation of enteric vaccines could significantly reduce child mortality from diarrheal diseases.
- This advancement holds promise for improving pediatric health outcomes in resource-limited settings.
- Further research and investment are warranted to overcome challenges and ensure vaccine accessibility.
Abstract:
Diarrheal diseases remain a major cause of death in children under 5 in less developed countries (LDCs). Vaccine development and implementation offers the best near-term approach to alleviating this problem. For this reason, a workshop to examine the possibilities for making enteric vaccines available to meet the specific needs of children in LDCs was convened in Virginia on April 24-26, 2004. Discussants considered research and development needs, regulatory and business issues, and previous experiences with enteric vaccine development and implementation. No insurmountable roadblocks to progress in this area were noted, and the possibility currently exists that properly supported efforts will enable the realization of enteric vaccines for pediatric use.
Related Concept Videos
Vaccinations
Microorganisms in Medicine and Therapeutics
Vaccine Production
Vaccines
Bacterial Gastroenteritis
Poliomyelitis

